Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials.

Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials.

BACKGROUND: The benefits of reducing blood pressure on the risks of major cardiovascular disease are well established, but uncertainty remains about the comparative effects of different blood-pressure-lowering regimens. We aimed to estimate effects of strategies based on different drug classes (ang...

Full description

Bibliographic Details
Main Author:	Turnbull, F
Format:	Journal article
Language:	English
Published:	2003

Similar Items

The effects of blood pressure reduction and of different blood pressure-lowering regimens on major cardiovascular events according to baseline blood pressure: meta-analysis of randomized trials
by: Czernichow, S, et al.
Published: (2011)

Blood pressure lowering and major cardiovascular events in people with and without chronic kidney disease: meta-analysis of randomised controlled trials.
by: Ninomiya, T, et al.
Published: (2013)

Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration.
by: Neal, B, et al.
Published: (2000)

Do men and women respond differently to blood pressure-lowering treatment? Results of prospectively designed overviews of randomized trials.
by: Turnbull, F, et al.
Published: (2008)

Protocol for prospective collaborative overviews of major randomized trials of blood-pressure-lowering treatments. World Health Organization-International Society of Hypertension Blood Pressure Lowering Treatment Trialists' Collaboration.
by: Black, H, et al.
Published: (1998)

Blood pressure lowering for cardiovascular disease
by: Collins, D, et al.
Published: (2016)

Effect of low sodium and high potassium diet on lowering blood pressure and cardiovascular events
by: Byung Sik Kim, et al.
Published: (2024-01-01)

Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial
by: Dahlöf, B, et al.
Published: (2005)

Effects of blood pressure lowering on cardiovascular events, in the context of regression to the mean: a systematic review of randomized trials
by: Salam, A, et al.
Published: (2018)

Blood pressure reduction and major cardiovascular events in people with and without type 2 diabetes - authors' reply
by: Nazarzadeh, M, et al.
Published: (2022)

Long‐Term Blood Pressure Variability and Major Adverse Cardiovascular and Cerebrovascular Events After Intracerebral Hemorrhage
by: Juan Pablo Castello, et al.
Published: (2022-03-01)

Sleep to lower elevated blood pressure: a randomised controlled trial (SLEPT)
by: McGrath, E, et al.
Published: (2016)

Blood pressure lowering and cardiovascular risk - Authors' reply.
by: Sundström, J, et al.
Published: (2014)

Blood pressure lowering for cardiovascular disease - Authors' reply
by: Ettehad, D, et al.
Published: (2016)

Effect of Different Blood-Pressure-Lowering Regimens on the Blood Pressure Control among Hypertensive Patients Treated in Hospital Conditions
by: Anna Paczkowska, et al.
Published: (2020-01-01)

Perindopril-based blood pressure lowering reduces major vascular events in Asian and Western participants with cerebrovascular disease: the PROGRESS trial
by: Arima, H, et al.
Published: (2010)

Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: a systematic review and meta-analysis
by: Lv, J, et al.
Published: (2012)

Blood Pressure and Cardiovascular Disease: Tracing the Steps From Framingham
by: Turnbull, F, et al.
Published: (2010)

Relationships between ankle blood pressure indices and major adverse cardiovascular events in people with and without type 2 diabetes
by: Kamel Mohammedi, et al.
Published: (2024-09-01)

Association of uncontrolled blood pressure in apparent treatment‐resistant hypertension with increased risk of major adverse cardiovascular events plus
by: George Bakris, et al.
Published: (2023-08-01)

Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: a systematic review and meta-analysis.
by: Jicheng Lv, et al.
Published: (2012-01-01)

Blood pressure-lowering treatment for the prevention of cardiovascular events in patients with atrial fibrillation: an individual participant data meta-analysis
by: Pinho-Gomes, A-C, et al.
Published: (2021)

Blood pressure-lowering treatment for the prevention of cardiovascular events in patients with atrial fibrillation: An individual participant data meta-analysis.
by: Ana-Catarina Pinho-Gomes, et al.
Published: (2021-06-01)

Prediction of cardiovascular events from systolic or diastolic blood pressure
by: Atefeh Talebi, et al.
Published: (2022-06-01)

Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data.
by: Sundström, J, et al.
Published: (2014)

Comparative review of the blood pressure-lowering and cardiovascular benefits of telmisartan and perindopril
by: Wang JG, et al.
Published: (2014-04-01)

Lowering blood pressure reduces renal events in type 2 diabetes.
by: de Galan, B, et al.
Published: (2009)

A Flexible Regimen of Combination Antihypertensive Therapy for Lower Blood Pressure to the Lower Target Level. Viewpoint of Cardiologist and Clinical Pharmacologist
by: S. R. Gilyarevskiy, et al.
Published: (2019-05-01)

Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context.
by: Collins, R, et al.
Published: (1990)

Effectiveness of lipid-lowering therapy on mortality and major adverse cardiovascular event outcomes in patients undergoing percutaneous coronary intervention: a network meta-analysis of randomised controlled trials
by: Ting-Ting Wu, et al.
Published: (2023-11-01)

Effect of CPAP on cardiovascular events in minimally symptomatic OSA: long-term follow-up of the MOSAIC randomised controlled trial
by: Tang, I, et al.
Published: (2020)

Simplified regimen for the management of hypertension with telemedicine and blood pressure self-monitoring (SIMPLE): study protocol for a randomised controlled trial
by: Yi Zhang, et al.
Published: (2022-03-01)

Cardiovascular events according to blood pressure thresholds recommended by ACC/AHA
by: Gowsini Joseph, et al.
Published: (2024-12-01)

Predictors of nonadherence with blood pressure regimens in hemodialysis
by: Kauric-Klein Z
Published: (2013-09-01)

Importance of mean blood pressure and blood pressure variability for the effect of valsartan versus amlodipine on cardiovascular events and death
by: Mehlum, MH, et al.
Published: (2018)

Gender-specific differences in central blood pressure and optimal target blood pressure based on the prediction of cardiovascular events
by: Min-Sik Kim, et al.
Published: (2022-10-01)

Association between omentin-1 and major cardiovascular events after lower extremity endovascular revascularization in diabetic patients: a prospective cohort study
by: Federico Biscetti, et al.
Published: (2020-10-01)

Effect of CPAP on cardiovascular events in minimally symptomatic OSA: long-term follow-up of the MOSAIC randomised controlled trial
by: John R Stradling, et al.
Published: (2020-09-01)

Effect of supplemental oxygen on blood pressure in obstructive sleep apnea (SOX): A randomised, CPAP withdrawal trial
by: Turnbull, C, et al.
Published: (2019)

Prospective comparison of non-invasive risk markers of major cardiovascular events in COPD patients
by: Jorge Zagaceta, et al.
Published: (2017-09-01)